Pioneering detection of Lupus Nephritis: A multi-center Scandinavian retrospective study
Our study, spanning multiple centers across Scandinavia, is at the forefront of identifying biomarkers for Lupus Nephritis within the broader category of chronic kidney disorders. We focus particularly on patients with autoimmune diseases that also affect kidney function. By utilizing rich biobanks and leveraging advanced OMICS techniques, our goal is to pinpoint proteins that can reliably indicate the presence of lupus nephritis. To confirm the effectiveness of these potential biomarkers, we are analyzing liquid biopsy samples, which include both urine and blood and kidney biopsies. Our efforts are supported by collaborations with leading institutions like Aarhus Hospital in Denmark and the Karolinska Institute in Sweden, both of which maintain comprehensive patient databases. This partnership enhances the robustness of our study and helps ensure that our findings are both accurate and replicable in external independent data sets.